N

Nittaya Phanuphak

HIV Netherlands Australia Thailand Research Collaboration

ORCID: 0000-0002-0036-3165

431 papers and 13.7k citations.

PubIndex Score72Top 28% · seniorHow it's scored

431Publications

13.7kTotal Citations

First publication: 2003First senior author: 2007

Top publicationsby citations

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Raphael J. Landovitz, Sheldon D. Fields, Suwat Chariyalertsak et al.|New England Journal of Medicine|2021

Cited by 847

Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand

Nittaya Phanuphak, Praphan Phanuphak|Sexual Health|2018

Cited by 130

Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

Mark A. Marzinke, Susan H. Eshleman, Beatriz Grinsztejn et al.|The Journal of Infectious Diseases|2021

Cited by 129

Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial

Alison Luckey, Manica Balasegaram, Lindley A. Barbee et al.|The Lancet|2025

Cited by 26

Indexing the rest of 431 publications…